XML 91 R48.htm IDEA: XBRL DOCUMENT v3.23.1
Investment in equity investees (Tables)
12 Months Ended
Dec. 31, 2022
Schedule of condensed financial information of the Group's equity investments
    
For the year ended December 31,
 
    
2020
    
2021
    
2022
 
    
(RMB in millions)
 
Revenues
     140,263        145,582        160,554
Gross profit
     45,590        39,736        47,369
Income/(loss) from operations
     5,157        1,877        (2,158 )
 
Net income/(loss)
     2,680        (250      (1,583 )
Net income/(loss) attributable to ordinary shareholders
     3,292        675        (1,327 )
 
 
  
As of December 31,
 
 
  
2021
 
  
2022
 
 
  
 
 
  
 
 
 
  
(RMB in millions)
 
Current assets
     150,304        149,946
Non-current
assets
     140,872        142,288
Current liabilities
     109,790        116,158
Non-current
liabilities
     49,919        54,494
Non-controlling
interests
     973        623
Yonghui Group  
Schedule of investment accounted for using equity method
Investment in Yonghui is accounted for using the equity method with the investment cost allocated as follows:
 
 
  
As of December 31,
 
 
  
2021
 
  
2022
 
 
  
 
 
  
 
 
 
  
(RMB in millions)
 
Carrying value of investment in Yonghui’s ordinary shares
     4,592        4,056  
Proportionate share of Yonghui’s net tangible and intangible assets
     2,225        1,768  
    
 
 
    
 
 
 
Positive basis difference
     2,367        2,288  
    
 
 
    
 
 
 
Positive basis difference has been assigned to:
                            
Goodwill (*)

     1,111        1,111  
Amortizable intangible assets (**)

     1,674        1,569  
Deferred tax liabilities
     (418      (392 )
 
    
 
 
    
 
 
 
       2,367        2,288  
    
 
 
    
 
 
 
 
(*)
In the third quarter of 2021, the Group conducted impairment assessments on its investment in Yonghui considering the duration and severity of the decline of Yonghui’s stock price after the investment, and concluded the decline in fair value of the investment was other-than-temporary. Accordingly, the Group recorded impairment charges of RMB1,492 million, to write down the carrying value of its investment in Yonghui to its fair value, based on quoted closing prices of Yonghui as of September 30, 2021.
(**)
As of December 31, 2022, the weighted average remaining life of the
amortizable 
intangible assets not included in Yonghui’s consolidated financial statements was 13
 
years.
Dada Group  
Schedule of investment accounted for using equity method
    
As of December 31,
2021
 
    
(RMB in millions)
 
Carrying value of investment in Dada’s ordinary shares
     6,075  
Proportionate share of Dada’s net tangible and intangible assets
     2,136  
    
 
 
 
Positive basis difference
     3,939  
    
 
 
 
Positive basis difference has been assigned to:
                   
Goodwill
     3,893  
Amortizable intangible assets
     61  
Deferred tax liabilities
     (15 )
 
    
 
 
 
       3,939  
    
 
 
 
ATRenew  
Schedule of investment accounted for using equity method
The investment in ATRenew is accounted for using the equity method with the investment cost allocated as follows:
 
 
  
As of December 31,
 
 
  
2021
 
  
2022
 
 
  
 
 
  
 
 
 
  
(RMB in millions)
 
Carrying value of investment in ATRenew’s ordinary shares
  
 
2,832
 
  
 
1,449
 
Proportionate share of ATRenew’s net tangible and intangible assets
  
 
2,209
 
  
 
2,080
 
 
  
 
 
 
  
 
 
 
Positive/(negative) basis difference
  
 
623
 
  
 
(631
 
  
 
 
 
  
 
 
 
Positive/(negative) basis difference has been assigned to:
  
     
  
     
Goodwill
 
(*)
  
 
35
 
  
 
—  
 
Amortizable intangible assets
 
(**)
  
 
784
 
  
 
(450
Deferred tax liabilities
  
 
(196
  
 
(181
 
  
 
 
 
  
 
 
 
 
  
 
623
 
  
 
(631
 
  
 
 
 
  
 
 
 

(*)
In the fourth quarter of 2021 and the second quarter of 2022, the Group conducted impairment assessments on its investment in ATRenew considering the duration and severity of the decline of ATRenew’s stock price after the investment, and concluded the decline in fair value of the investment was other-than-temporary. Accordingly, the Group recorded impairment charges of RMB3,909 million and RMB1,191 million, respectively, to write down the carrying value of its investment in ATRenew to its fair value, based on quoted closing prices of ATRenew as of December 31, 2021 and June 30, 2022, respectively.
(**)
As of December 31, 2022, the negative basis difference between carrying value of investment in ATRenew and proportionate share of ATRenew’s net tangible and intangible assets was RMB631 million. This difference would not be amortized.